{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:43:46Z","timestamp":1792122226781,"version":"4.4.0"},"reference-count":48,"publisher":"Impact Journals, LLC","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2014,11,15]]},"DOI":"10.18632\/oncotarget.2084","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T23:37:14Z","timestamp":1442360234000},"page":"10393-10406","source":"Crossref","is-referenced-by-count":44,"title":["Notch signaling drives multiple myeloma induced osteoclastogenesis"],"prefix":"10.18632","volume":"5","author":[{"given":"Michela","family":"Colombo","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Universit\u00e0 degli Studi di Milano, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Th\u00fcmmler","sequence":"additional","affiliation":[{"name":"Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Mirandola","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Universit\u00e0 degli Studi di Milano, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Garavelli","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Universit\u00e0 degli Studi di Milano, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Todoerti","sequence":"additional","affiliation":[{"name":"Laboratory of Pre-Clinical and Translational Research, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Apicella","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Universit\u00e0 degli Studi di Milano, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Lazzari","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Universit\u00e0 degli Studi di Milano, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuigia","family":"Lancellotti","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Universit\u00e0 degli Studi di Milano, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Platonova","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Universit\u00e0 degli Studi di Milano, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeed","family":"Akbar","sequence":"additional","affiliation":[{"name":"Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Chiriva-Internati","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Soutar","sequence":"additional","affiliation":[{"name":"Beatson West of Scotland Cancer Centre, Haemato-oncology Service, Gartnavel Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Neri","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, Universit\u00e0 degli Studi di Milano; Hematology, Fondazione C\u00e0 Granda IRCCS Policlinico, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl S.","family":"Goodyear","sequence":"additional","affiliation":[{"name":"Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Chiaramonte","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Universit\u00e0 degli Studi di Milano, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2014,6,9]]},"reference":[{"issue":"11","key":"1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Anderson","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Greipp","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/leu.2013.6","article-title":"Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes","volume":"27","author":"Chiaramonte","year":"2013","journal-title":"Leukemia"},{"issue":"7","key":"4","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/leu.2013.27","article-title":"Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4\/SDF-1","volume":"27","author":"Chiaramonte","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2141.2004.05018.x","article-title":"Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation","volume":"126","author":"Schneider","year":"2004","journal-title":"Br J Haematol"},{"issue":"16","key":"6","doi-asserted-by":"crossref","first-page":"6840","DOI":"10.1158\/0008-5472.CAN-08-0402","article-title":"CC-chemokine ligand 20\/macrophage inflammatory protein-3alpha and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions","volume":"68","author":"Rizzoli","year":"2008","journal-title":"Cancer Res"},{"issue":"3","key":"7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.exphem.2004.11.015","article-title":"MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells","volume":"33","author":"Roodman","year":"2005","journal-title":"Exp Hematol"},{"issue":"10","key":"8","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1182\/blood-2007-05-093294","article-title":"MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts","volume":"110","author":"Mukherjee","year":"2007","journal-title":"Blood"},{"issue":"20","key":"9","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.201394498","article-title":"Multiple myeloma disrupts the TRANCE\/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression","volume":"98","author":"Choi","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2141.2010.08141.x","article-title":"Advances in the understanding of myeloma bone disease and tumour growth","volume":"149","author":"Yaccoby","year":"2010","journal-title":"Br J Haematol"},{"issue":"1","key":"11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bone.2010.08.004","article-title":"TGF-beta in cancer and bone: implications for treatment of bone metastases","volume":"48","author":"Guise","year":"2011","journal-title":"Bone"},{"issue":"3","key":"12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1158\/1078-0432.CCR-06-2258","article-title":"Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin","volume":"13","author":"Matsumoto","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"12","key":"13","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1600-0463.2007.00751.x","article-title":"Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias","volume":"115","author":"Yoo","year":"2007","journal-title":"Apmis"},{"issue":"5","key":"14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bcp.2010.03.026","article-title":"Notch signaling: emerging molecular targets for cancer therapy","volume":"80","author":"Liu","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2004.07.022","article-title":"A wide role for NOTCH1 signaling in acute leukemia","volume":"219","author":"Comi","year":"2005","journal-title":"Cancer Lett"},{"issue":"1","key":"16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2011.05.009","article-title":"Notch-ing from T-cell to B-cell lymphoid malignancies","volume":"308","author":"Chiaramonte","year":"2011","journal-title":"Cancer Lett"},{"issue":"5694","key":"17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Aster","year":"2004","journal-title":"Science"},{"issue":"11","key":"18","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.leukres.2006.07.009","article-title":"Still puzzling Notch signaling in B-cell malignancies","volume":"30","author":"Chiaramonte","year":"2006","journal-title":"Leuk Res"},{"issue":"10","key":"19","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/blood.V99.10.3742","article-title":"Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia","volume":"99","author":"Berger","year":"2002","journal-title":"Blood"},{"issue":"7","key":"20","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.11635","article-title":"NOTCH2 mutations in marginal zone lymphoma","volume":"93","author":"Delabie","year":"2008","journal-title":"Haematologica"},{"issue":"10","key":"21","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1158\/0008-5472.CAN-08-3467","article-title":"Loss of the SMRT\/NCoR2 corepressor correlates with JAG2 overexpression in multiple myeloma","volume":"69","author":"Coignet","year":"2009","journal-title":"Cancer Res"},{"issue":"9","key":"22","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1182\/blood-2003-07-2254","article-title":"Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells","volume":"103","author":"Dorken","year":"2004","journal-title":"Blood"},{"issue":"12","key":"23","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.humpath.2010.05.002","article-title":"Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"41","author":"Dominis","year":"2010","journal-title":"Hum Pathol"},{"issue":"12","key":"24","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1182\/blood-2003-12-4114","article-title":"Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines","volume":"104","author":"Coignet","year":"2004","journal-title":"Blood"},{"issue":"6","key":"25","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0002-9440(10)62491-1","article-title":"Skeletrophin, a novel ubiquitin ligase to the intracellular region of Jagged-2, is aberrantly expressed in multiple myeloma","volume":"166","author":"Ohtsuki","year":"2005","journal-title":"Am J Pathol"},{"issue":"4","key":"26","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2007-07-102632","article-title":"Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy","volume":"111","author":"Gabrilovich","year":"2008","journal-title":"Blood"},{"issue":"10","key":"27","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1074\/jbc.M707000200","article-title":"NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells","volume":"283","author":"Teitelbaum","year":"2008","journal-title":"J Biol Chem"},{"issue":"20","key":"28","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1128\/MCB.00299-08","article-title":"The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis","volume":"28","author":"Okabe","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"2","key":"29","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar3758","article-title":"Differential regulation of osteoclastogenesis by Notch2\/Delta-like 1 and Notch1\/Jagged1 axes","volume":"14","author":"Yagita","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"30","first-page":"7064","article-title":"Notch is activated in RANKL-induced osteoclast differentiation and resorption","volume":"13","author":"Ren","year":"2008","journal-title":"Front Biosci"},{"issue":"12","key":"31","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1158\/1078-0432.CCR-12-3461","article-title":"Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome","volume":"19","author":"Offidani","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"2","key":"32","first-page":"275","article-title":"Lack of receptor activator of nuclear factor-kB ligand (RANKL) expression and functional production by human multiple myeloma cells","volume":"90","author":"Rizzoli","year":"2005","journal-title":"Haematologica"},{"issue":"4","key":"33","first-page":"1436","article-title":"Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma","volume":"9","author":"Sezer","year":"2003","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"2","key":"34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ccr.2010.12.022","article-title":"Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells","volume":"19","author":"Kang","year":"2011","journal-title":"Cancer Cell"},{"issue":"4","key":"35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12185-011-0949-x","article-title":"Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma","volume":"94","author":"Abe","year":"2011","journal-title":"Int J Hematol"},{"issue":"4","key":"36","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1182\/blood-2010-04-279760","article-title":"Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration","volume":"117","author":"Klein","year":"2011","journal-title":"Blood"},{"issue":"12","key":"37","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/leu.2008.138","article-title":"Notch inhibition blocks multiple myeloma cell-induced osteoclast activation","volume":"22","author":"Jundt","year":"2008","journal-title":"Leukemia"},{"issue":"9","key":"38","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2003-07-2340","article-title":"Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines","volume":"103","author":"Gabrilovich","year":"2004","journal-title":"Blood"},{"issue":"10","key":"39","first-page":"192","article-title":"MRK003, a gamma-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma","volume":"9","author":"Kumar","year":"2011","journal-title":"Leukemia"},{"issue":"6","key":"40","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/leu.2011.332","article-title":"Dll1\/Notch activation accelerates multiple myeloma disease development by promoting CD138+ MM-cell proliferation","volume":"26","author":"Van Valckenborgh","year":"2012","journal-title":"Leukemia"},{"issue":"6","key":"41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s13402-011-0060-6","article-title":"Gamma-secretase inhibitor enhances the cytotoxic effect of bortezomib in multiple myeloma","volume":"34","author":"Nefedova","year":"2011","journal-title":"Cell Oncol"},{"issue":"17","key":"42","first-page":"5438","article-title":"Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo","volume":"63","author":"Zannettino","year":"2003","journal-title":"Cancer Res"},{"issue":"4","key":"43","first-page":"1436","article-title":"Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma","volume":"9","author":"Sezer","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"2","key":"44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2141.2002.03257.x","article-title":"Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity","volume":"116","author":"Epstein","year":"2002","journal-title":"Br J Haematol"},{"issue":"9","key":"45","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s00198-013-2313-x","article-title":"NF-kappaB signaling and bone resorption","volume":"24","author":"Abu-Amer","year":"2013","journal-title":"Osteoporos Int"},{"issue":"1","key":"46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbamcr.2012.10.018","article-title":"Calcium\/calmodulin-dependent protein kinase IV (CaMKIV) enhances osteoclast differentiation via the up-regulation of Notch1 protein stability","volume":"1833","author":"Park","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"47","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","article-title":"Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles","volume":"183","author":"Scott","year":"1996","journal-title":"J Exp Med"},{"issue":"3","key":"48","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.23048","article-title":"Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice","volume":"50","author":"Bettler","year":"2009","journal-title":"Hepatology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T20:59:23Z","timestamp":1589403563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,9]]},"references-count":48,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2014,11,15]]}},"alternative-id":["2084","25257302"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.2084","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,9]]}}}